122 related articles for article (PubMed ID: 32494799)
1. Grafting multi-maleimides on antisense oligonucleotide to enhance its cellular uptake and gene silencing capability.
Guo Y; Zhang J; Pan G; Choi CHJ; Wang P; Li Y; Zhu X; Zhang C
Chem Commun (Camb); 2020 Jul; 56(54):7439-7442. PubMed ID: 32494799
[TBL] [Abstract][Full Text] [Related]
2. Efficient in vivo delivery of antisense oligonucleotide to choroid plexus.
Piao W; Nishina K; Yoshida-Tanaka K; Kuwahara H; Nishina T; Sakata M; Mizusawa H; Yokota T
J Med Dent Sci; 2013 Mar; 60(1):9-16. PubMed ID: 23917958
[TBL] [Abstract][Full Text] [Related]
3. Gene silencing using a conjugate comprising Tat peptide and antisense oligonucleotide with phosphorothioate backbones.
Maegawa Y; Mochizuki S; Miyamoto N; Sakurai K
Bioorg Med Chem Lett; 2016 Feb; 26(4):1276-8. PubMed ID: 26774656
[TBL] [Abstract][Full Text] [Related]
4. Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes.
Tanowitz M; Hettrick L; Revenko A; Kinberger GA; Prakash TP; Seth PP
Nucleic Acids Res; 2017 Dec; 45(21):12388-12400. PubMed ID: 29069408
[TBL] [Abstract][Full Text] [Related]
5. On the role of methacrylic acid copolymers in the intracellular delivery of antisense oligonucleotides.
Yessine MA; Meier C; Petereit HU; Leroux JC
Eur J Pharm Biopharm; 2006 May; 63(1):1-10. PubMed ID: 16364618
[TBL] [Abstract][Full Text] [Related]
6. Topical gene silencing by iontophoretic delivery of an antisense oligonucleotide-dendrimer nanocomplex: the proof of concept in a skin cancer mouse model.
Venuganti VV; Saraswathy M; Dwivedi C; Kaushik RS; Perumal OP
Nanoscale; 2015 Mar; 7(9):3903-14. PubMed ID: 25436837
[TBL] [Abstract][Full Text] [Related]
7. A naked antisense oligonucleotide with phosphorothioate linkages is taken up intracellularly more efficiently but functions less effectively.
Takahashi M; Seki M; Nashimoto M
Biochem Biophys Res Commun; 2021 Oct; 573():140-144. PubMed ID: 34411896
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides.
Wada S; Yasuhara H; Wada F; Sawamura M; Waki R; Yamamoto T; Harada-Shiba M; Obika S
J Control Release; 2016 Mar; 226():57-65. PubMed ID: 26855051
[TBL] [Abstract][Full Text] [Related]
9. Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides.
Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
Nucleic Acids Res; 2017 May; 45(9):5309-5322. PubMed ID: 28379543
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of multivalent fatty acid-conjugated antisense oligonucleotides: Cell internalization, physical properties, and in vitro and in vivo activities.
Tanaka Y; Tanioku Y; Nakayama T; Aso K; Yamaguchi T; Kamada H; Obika S
Bioorg Med Chem; 2023 Mar; 81():117192. PubMed ID: 36780806
[TBL] [Abstract][Full Text] [Related]
11. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
12. Effect of 2'-O-[2-[2-(N,N-dimethylamino)ethoxy]ethyl] modification on activity of gapmer antisense oligonucleotides containing 2',4'-constrained 2'-O-ethyl nucleic acid.
Pandey SK; Nowak A; Perkins J; Ferng A; Prakash TP
Bioorg Med Chem Lett; 2015 Apr; 25(8):1688-1691. PubMed ID: 25804718
[TBL] [Abstract][Full Text] [Related]
13. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids.
Zelphati O; Szoka FC
Pharm Res; 1996 Sep; 13(9):1367-72. PubMed ID: 8893276
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
Zhang C; Pei J; Kumar D; Sakabe I; Boudreau HE; Gokhale PC; Kasid UN
Methods Mol Biol; 2007; 361():163-85. PubMed ID: 17172711
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a specific intracellular localization of an antisense oligonucleotide in k562 cells.
Vasconcelos MH; Maia LF; Sousa C; Beleza SS; Guimarães JE
J Pharmacol Sci; 2005 Sep; 99(1):105-8. PubMed ID: 16141637
[TBL] [Abstract][Full Text] [Related]
16. Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides.
Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
Nucleic Acids Res; 2016 Sep; 44(15):7314-30. PubMed ID: 27378781
[TBL] [Abstract][Full Text] [Related]
17. Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15.
Nakai D; Seita T; Terasaki T; Iwasa S; Shoji Y; Mizushima Y; Sugiyama Y
J Pharmacol Exp Ther; 1996 Sep; 278(3):1362-72. PubMed ID: 8819524
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle.
Prakash TP; Mullick AE; Lee RG; Yu J; Yeh ST; Low A; Chappell AE; Østergaard ME; Murray S; Gaus HJ; Swayze EE; Seth PP
Nucleic Acids Res; 2019 Jul; 47(12):6029-6044. PubMed ID: 31127296
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.
Roth CM
Biophys J; 2005 Oct; 89(4):2286-95. PubMed ID: 16055530
[TBL] [Abstract][Full Text] [Related]
20. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.
Liang XH; Shen W; Sun H; Kinberger GA; Prakash TP; Nichols JG; Crooke ST
Nucleic Acids Res; 2016 May; 44(8):3892-907. PubMed ID: 26945041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
